Evidence map›Paper›PMID 26938526›Full record

ArticleInternational journal of molecular sciences2016

5-Methoxyl Aesculetin Abrogates Lipopolysaccharide-Induced Inflammation by Suppressing MAPK and AP-1 Pathways in RAW 264.7 Cells.

Lei Wu, Xueqin Li, Haifeng Wu, Wei Long, Xiaojian Jiang, Ting Shen, Qian Qiang, Chuanling Si, Xinfeng Wang, Yunyao Jiang and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 36 citations in OpenAlex.

  1. Anti-Inflammatory Effects of ParaprobioticJournal of microbiology and biotechnology · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Anti-Inflammatory Effects ofBioMed research international · 2022
    Article
  6. CD200 ModulatesInternational journal of molecular sciences · 2019
    Article
  7. Article
  8. Article
  9. Evidence-based complementary and alternative medicine : eCAM · 2017
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Lei WuTianjin Key Laboratory of Pulp & Paper, Tianjin University of Science & Technology, Tianjin 300457, China. wulei858196@163.com.
Xueqin LiDepartment of Gerontology, Huai'an First People's Hospital, Nanjing Medical University, Huaian 223300, China. wgc1955@sina.com.
Haifeng WuKey Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100193, China. hfwu@implad.ac.cn.
Wei LongInstitute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China. longway@irm-cams.ac.cn.
Xiaojian JiangJiangsu Collaborative Innovation Center of Regional Modern Agriculture & Environmental Protection/Jiangsu Key Laboratory for Eco-Agricultural Biotechnology around Hongze Lake, Huaiyin Normal University, Huaian 223300, China. jiangxj@hytc.edu.cn.
Ting ShenJiangsu Collaborative Innovation Center of Regional Modern Agriculture & Environmental Protection/Jiangsu Key Laboratory for Eco-Agricultural Biotechnology around Hongze Lake, Huaiyin Normal University, Huaian 223300, China. shenting1019@163.com.
Qian QiangJiangsu Collaborative Innovation Center of Regional Modern Agriculture & Environmental Protection/Jiangsu Key Laboratory for Eco-Agricultural Biotechnology around Hongze Lake, Huaiyin Normal University, Huaian 223300, China. qiangqian9197@126.com.
Chuanling SiTianjin Key Laboratory of Pulp & Paper, Tianjin University of Science & Technology, Tianjin 300457, China. sichli@tust.edu.cn.
Xinfeng WangJiangsu Collaborative Innovation Center of Regional Modern Agriculture & Environmental Protection/Jiangsu Key Laboratory for Eco-Agricultural Biotechnology around Hongze Lake, Huaiyin Normal University, Huaian 223300, China. hywdwxf@sohu.com.
Yunyao JiangDepartment of Medical Biotechnology, College of Biomedical Science, Kangwon National University, Chuncheon 200-701, Korea. yunyao@kangwon.ac.kr.
Weicheng HuJiangsu Collaborative Innovation Center of Regional Modern Agriculture & Environmental Protection/Jiangsu Key Laboratory for Eco-Agricultural Biotechnology around Hongze Lake, Huaiyin Normal University, Huaian 223300, China. hu_weicheng@163.com.
Huaiyin Normal University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNTianjin University of Science and Technology · CNHuaian First People’s Hospital · CNKangwon National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For the first time, a pale amorphous coumarin derivative, 5-methoxyl aesculetin (MOA), was isolated from the dried bark of Fraxinus rhynchophylla Hance (Oleaceae). MOA modulates cytokine expression in lipopolysaccharide (LPS)-treated RAW 264.7 macrophages, but the precise mechanisms are still not fully understood. We determined the effects of MOA on the production of inflammatory mediators and pro-inflammatory cytokines in the LPS-induced inflammatory responses of RAW 264.7 macrophages. MOA significantly inhibited the LPS-induced production of nitric oxide (NO), prostaglandin E₂ (PGE₂), tumor necrosis factor-α (TNF-α), interleukin-6, and interleukin-1β. It also effectively attenuated inducible nitric oxide (NO) synthase, cyclooxygenase-2, and TNF-α mRNA expression and significantly decreased the levels of intracellular reactive oxygen species. It inhibited phosphorylation of the extracellular signal-regulated kinase (ERK1/2), thus blocking nuclear translocation of activation protein (AP)-1. In a molecular docking study, MOA was shown to target the binding site of ERK via the formation of three hydrogen bonds with two residues of the kinase, which is sufficient for the inhibition of ERK. These results suggest that the anti-inflammatory effects of MOA in RAW 264.7 macrophages derive from its ability to block both the activation of mitogen-activated protein kinases (MAPKs) and one of their downstream transcription factors, activator protein-1 (AP-1). Our observations support the need for further research into MOA as a promising therapeutic agent in inflammatory diseases.

Indexed as

MAP Kinase Signaling SystemAnimalsAntioxidantsCell LineCyclooxygenase 2DinoprostoneInterleukinsLipopolysaccharidesMacrophagesMiceMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Nitric OxideTranscription Factor AP-1Tumor Necrosis Factor-alphaUmbelliferonesAntioxidantsCyclooxygenase 2DinoprostoneesculetinInterleukinsLipopolysaccharidesMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Nitric OxideTranscription Factor AP-1Tumor Necrosis Factor-alphaUmbelliferones5-methoxyl aesculetinactivator protein-1inflammationmitogen-activated protein kinases

Identifiers

PMID26938526
PMCPMC4813178
OpenAlexW2289517083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.